Hamill Laura Insider Trades

Insider Trading History

Track insider trading activity for Hamill Laura. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $0 0 shares
Last Trade
Sep 16, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$50.1k 5,825 shares
$8.60
$8.61
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $0 0 shares
Last Trade
Sep 16, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$998k 115,945 shares
$8.61
$8.61
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc JAZZ
Director
Holding Value $1.6M 6,933 shares
Last Trade
Aug 08, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$201k 1,805 shares
$111.25
$230.93
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc JAZZ
Director
Holding Value $2.02M 8,738 shares
Last Trade
Aug 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$393k 3,507 shares
$112.08
$230.93
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $288k 33,450 shares
Last Trade
Jun 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 33,450 shares
$4.51
$8.61
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc JAZZ
Director
Holding Value $1.21M 5,231 shares
Last Trade
Aug 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$423k 3,731 shares
$113.26
$230.93
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $125k 14,545 shares
Last Trade
Jun 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 14,545 shares
$12.01
$8.61
Pardes Biosciences
Pardes Biosciences PRDS
Director
Holding Value $0 0 shares
Last Trade
Aug 31, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$480k 220,390 shares
$2.18
$2.18
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $120k 13,950 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$113k 13,950 shares
$8.13
$8.61
Pardes Biosciences
Pardes Biosciences PRDS
Director
Holding Value $81.8k 37,500 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.1k 37,500 shares
$1.87
$2.18
Scilex Holding Company - Warrants (10/11/2027)
Scilex Holding Company - Warrants (10/11/2027) SCLXW
Director
Holding Value $34.9k 250,000 shares
Last Trade
Jan 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$230k 250,000 shares
$0.92
$0.14
Vickers Vantage I
Vickers Vantage I VCKA
Director
Holding Value $2.25M 250,000 shares
Last Trade
Jan 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.34M 250,000 shares
$9.35
$9.01
Vickers Vantage I - Warrants (15/09/2027)
Vickers Vantage I - Warrants (15/09/2027) VCKAW
Director
Holding Value $34.6k 250,000 shares
Last Trade
Jan 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.1k 250,000 shares
$0.16
$0.14
Scilex Holding Company
Scilex Holding Company SCLX
Director
Holding Value $1.79M 250,000 shares
Last Trade
Jan 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.7M 250,000 shares
$282.80
$7.17
Y-Mabs Therapeutics
Y-Mabs Therapeutics YMAB
Director
Holding Value $138k 16,000 shares
Last Trade
Jul 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$266k 16,000 shares
$16.64
$8.61
Pardes Biosciences
Pardes Biosciences PRDS
Director
Holding Value $81.8k 37,500 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$391k 75,000 shares
$5.21
$2.18
AnaptysBio
AnaptysBio ANAB
Director
Holding Value $471k 9,200 shares
Last Trade
Feb 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$280k 9,200 shares
$30.44
$51.24
FS Development II
FS Development II FSII
Director
Holding Value $735k 75,000 shares
Last Trade
Dec 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$735k 75,000 shares
$9.80
$9.80
Pardes Biosciences
Pardes Biosciences PRDS
Director
Holding Value $0 0 shares
Last Trade
Dec 23, 2021 Sale
No data
No data
$2.18
Pardes Biosciences
Pardes Biosciences PRDS
Director
Holding Value $164k 75,000 shares
Last Trade
Dec 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$2.18

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up